This formulation improved the oxygenation status of the Tumor Microenvironment, reduced the expression of PD-L1, reversed T cell exhaustion, significantly suppressed tumor growth, and induced ICD, thereby activating a T cell-mediated antitumor immune response (140). The gene discussed is CD274; the disease is neoplasm.